ArticleResearch square2026
Urolithin A preserves renal perfusion and function and attenuates inflammasome-associated signaling in a translational porcine model of sepsis-induced acute kidney injury.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Sepsis-associated acute kidney injury (SA-AKI) is a major complication of critical illness for which no targeted therapy is available. Urolithin A (UA), a gut microbiota-derived metabolite with anti-inflammatory and antioxidant properties, has shown organ-protective effects in preclinical studies, but its effects on renal physiology during sepsis remain unknown. We evaluated UA in a translational porcine model of autologous fecal peritonitis-induced sepsis using 6-8-week-old male Landrace × Large White crossbred pigs. Animals were assigned to sham, fecal peritonitis (FP), or FP plus intravenous UA administered after sepsis induction. At 24 hours, systemic and renal hemodynamics, glomerular filtration rate (GFR), kidney injury biomarkers, inflammatory and oxidative stress indices, and renal inflammasome-associated proteins were assessed. Complementary studies used lipopolysaccharide-challenged primary porcine proximal tubular epithelial cells. FP produced a hypodynamic septic phenotype with systemic and renal hypoperfusion, increased renal vascular resistance, decreased GFR, and increased kidney injury biomarkers. UA attenuated hemodynamic abnormalities, preserved GFR, and reduced kidney injury, inflammation, and oxidative stress. FP increased renal immunoreactivity for NLR family pyrin domain containing 3 (NLRP3), apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), cleaved caspase-1, gasdermin D N-terminal fragment, interleukin-1β, and interleukin-18; these responses were attenuated by UA. In porcine proximal tubular cells, UA reduced LPS-induced caspase-1 activity and expression of NLRP3, cleaved caspase-1, and gasdermin D N-terminal fragment. These findings demonstrate renal physiological protection by UA in a large-animal model of polymicrobial sepsis and support further evaluation of UA as an adjunctive intervention for SA-AKI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.